Company Description

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States.

The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.

It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components.

The company is based in Redwood City, California.

Biotricity, Inc.

Country	United States
Industry	Medical Devices
Sector	Healthcare
Employees	55
CEO	Dr. Waqaas Al-Siddiq Ph.D.

Contact Details

Address: 203 Redwood Parkway, Suite 600 Redwood City, California 94065 United States
Phone	(650) 832-1626
Website	biotricity.com

Stock Details

Ticker Symbol	BTCY
Exchange	NASDAQ
Fiscal Year	April - March
Reporting Currency	USD
CIK Code	0001630113
CUSIP Number	09074H104
ISIN Number	US09074H2031
Employer ID	47-2548273
SIC Code	3841

Key Executives

Name	Position
Dr. Waqaas Al-Siddiq Ph.D.	Founder, President, Chief Executive Officer and Chairman
S. John Ayanoglou	Chief Financial Officer
Andy Wong	Vice President of Operations
Dr. George N. Nikopoulos	Director of Business Development
Matt Zabel	Vice President of Sales and Strategy
Amir Ali	Chief Development Officer

Latest SEC Filings

Date	Type	Title
Apr 23, 2024	8-K	Current Report
Apr 23, 2024	424B3	Prospectus
Apr 9, 2024	D	Notice of Exempt Offering of Securities
Apr 3, 2024	8-K	Current Report
Mar 26, 2024	8-K	Current Report
Feb 28, 2024	S-1	General form for registration of securities under the Securities Act of 1933
Feb 20, 2024	10-Q	Quarterly Report
Feb 14, 2024	NT 10-Q	Notification of inability to timely file Form 10-Q or 10-QSB
Feb 2, 2024	8-K	Current Report
Nov 14, 2023	10-Q	Quarterly Report

View All SEC Filings